Titre : Amérique centrale

Amérique centrale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amérique centrale : Questions médicales les plus fréquentes", "headline": "Amérique centrale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amérique centrale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amérique centrale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Amériques", "url": "https://questionsmedicales.fr/mesh/D000569", "about": { "@type": "MedicalCondition", "name": "Amériques", "code": { "@type": "MedicalCode", "code": "D000569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Belize", "alternateName": "Belize", "url": "https://questionsmedicales.fr/mesh/D001531", "about": { "@type": "MedicalCondition", "name": "Belize", "code": { "@type": "MedicalCode", "code": "D001531", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.133" } } }, { "@type": "MedicalWebPage", "name": "Costa Rica", "alternateName": "Costa Rica", "url": "https://questionsmedicales.fr/mesh/D003364", "about": { "@type": "MedicalCondition", "name": "Costa Rica", "code": { "@type": "MedicalCode", "code": "D003364", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.238" } } }, { "@type": "MedicalWebPage", "name": "Salvador", "alternateName": "El Salvador", "url": "https://questionsmedicales.fr/mesh/D004544", "about": { "@type": "MedicalCondition", "name": "Salvador", "code": { "@type": "MedicalCode", "code": "D004544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.339" } } }, { "@type": "MedicalWebPage", "name": "Guatemala", "alternateName": "Guatemala", "url": "https://questionsmedicales.fr/mesh/D006166", "about": { "@type": "MedicalCondition", "name": "Guatemala", "code": { "@type": "MedicalCode", "code": "D006166", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.454" } } }, { "@type": "MedicalWebPage", "name": "Honduras", "alternateName": "Honduras", "url": "https://questionsmedicales.fr/mesh/D006721", "about": { "@type": "MedicalCondition", "name": "Honduras", "code": { "@type": "MedicalCode", "code": "D006721", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.534" } } }, { "@type": "MedicalWebPage", "name": "Nicaragua", "alternateName": "Nicaragua", "url": "https://questionsmedicales.fr/mesh/D009527", "about": { "@type": "MedicalCondition", "name": "Nicaragua", "code": { "@type": "MedicalCode", "code": "D009527", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.690" } } }, { "@type": "MedicalWebPage", "name": "Panama", "alternateName": "Panama", "url": "https://questionsmedicales.fr/mesh/D010176", "about": { "@type": "MedicalCondition", "name": "Panama", "code": { "@type": "MedicalCode", "code": "D010176", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169.772" } } } ], "about": { "@type": "MedicalCondition", "name": "Amérique centrale", "alternateName": "Central America", "code": { "@type": "MedicalCode", "code": "D002489", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dylan E Graetz", "url": "https://questionsmedicales.fr/author/Dylan%20E%20Graetz", "affiliation": { "@type": "Organization", "name": "Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee." } }, { "@type": "Person", "name": "Yichen Chen", "url": "https://questionsmedicales.fr/author/Yichen%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee." } }, { "@type": "Person", "name": "Meenakshi Devidas", "url": "https://questionsmedicales.fr/author/Meenakshi%20Devidas", "affiliation": { "@type": "Organization", "name": "Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee." } }, { "@type": "Person", "name": "Federico Antillon-Klussmann", "url": "https://questionsmedicales.fr/author/Federico%20Antillon-Klussmann", "affiliation": { "@type": "Organization", "name": "National Unit of Pediatric Oncology, Francisco Marroquin University School of Medicine, Guatemala City, Guatemala." } }, { "@type": "Person", "name": "Ligia Fu", "url": "https://questionsmedicales.fr/author/Ligia%20Fu", "affiliation": { "@type": "Organization", "name": "Pediatric Hematology and Oncology Unit, Tegucigalpa School Hospital, Tegucigalpa, Honduras." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Management Options for Linear Scleroderma (\"En Coup de Sabre\").", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35985009", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DSS.0000000000003539" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.", "datePublished": "2022-07-31", "url": "https://questionsmedicales.fr/article/35921989", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.autrev.2022.103162" } }, { "@type": "ScholarlyArticle", "name": "Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36304460", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1004949" } }, { "@type": "ScholarlyArticle", "name": "[Localized scleroderma].", "datePublished": "2024-02-16", "url": "https://questionsmedicales.fr/article/38363312", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00105-024-05297-9" } }, { "@type": "ScholarlyArticle", "name": "Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36281773", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/art.42380" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Amériques", "item": "https://questionsmedicales.fr/mesh/D000569" }, { "@type": "ListItem", "position": 4, "name": "Amérique centrale", "item": "https://questionsmedicales.fr/mesh/D002489" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amérique centrale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amérique centrale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amérique centrale", "description": "Comment diagnostiquer le paludisme en Amérique centrale ?\nQuels tests pour la dengue ?\nComment identifier la leptospirose ?\nQuels signes indiquent une infection parasitaire ?\nComment diagnostiquer le virus Zika ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amérique centrale", "description": "Quels sont les symptômes de la dengue ?\nQuels signes de la leptospirose ?\nQuels symptômes du paludisme ?\nComment reconnaître le virus Zika ?\nQuels symptômes d'une infection parasitaire ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amérique centrale", "description": "Comment prévenir la dengue ?\nQuelles mesures contre le paludisme ?\nComment éviter la leptospirose ?\nQuelles précautions pour le virus Zika ?\nComment prévenir les infections parasitaires ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amérique centrale", "description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la leptospirose ?\nComment traiter le virus Zika ?\nQuels médicaments pour infections parasitaires ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amérique centrale", "description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la leptospirose ?\nQuelles complications du virus Zika ?\nQuelles complications des infections parasitaires ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amérique centrale", "description": "Quels sont les facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la leptospirose ?\nQuels facteurs de risque pour le virus Zika ?\nQuels facteurs de risque pour les infections parasitaires ?", "url": "https://questionsmedicales.fr/mesh/D002489?mesh_terms=Scleroderma,+Localized&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le paludisme en Amérique centrale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter le parasite du paludisme." } }, { "@type": "Question", "name": "Quels tests pour la dengue ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et PCR sont utilisés pour confirmer une infection par le virus de la dengue." } }, { "@type": "Question", "name": "Comment identifier la leptospirose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par des tests sérologiques et l'historique d'exposition à l'eau contaminée." } }, { "@type": "Question", "name": "Quels signes indiquent une infection parasitaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la diarrhée, la fièvre et la fatigue peuvent indiquer une infection parasitaire." } }, { "@type": "Question", "name": "Comment diagnostiquer le virus Zika ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests sanguins pour détecter le virus ou les anticorps." } }, { "@type": "Question", "name": "Quels sont les symptômes de la dengue ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, douleurs articulaires, éruptions cutanées et fatigue." } }, { "@type": "Question", "name": "Quels signes de la leptospirose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, douleurs musculaires et éruptions cutanées sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes du paludisme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et fatigue sont des symptômes typiques." } }, { "@type": "Question", "name": "Comment reconnaître le virus Zika ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, éruptions cutanées, douleurs articulaires et conjonctivite." } }, { "@type": "Question", "name": "Quels symptômes d'une infection parasitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les infections parasitaires peuvent causer diarrhée, douleurs abdominales et fatigue." } }, { "@type": "Question", "name": "Comment prévenir la dengue ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Quelles mesures contre le paludisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Comment éviter la leptospirose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec des eaux potentiellement contaminées et porter des bottes." } }, { "@type": "Question", "name": "Quelles précautions pour le virus Zika ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs et éviter les zones à risque de moustiques." } }, { "@type": "Question", "name": "Comment prévenir les infections parasitaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer une bonne hygiène, laver les aliments et éviter l'eau contaminée." } }, { "@type": "Question", "name": "Quel traitement pour la dengue ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le paludisme est traité avec des antipaludiques comme la chloroquine ou l'artémisinine." } }, { "@type": "Question", "name": "Quel traitement pour la leptospirose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques comme la doxycycline sont utilisés pour traiter la leptospirose." } }, { "@type": "Question", "name": "Comment traiter le virus Zika ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés." } }, { "@type": "Question", "name": "Quels médicaments pour infections parasitaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des antiparasitaires comme le mébendazole ou l'albendazole sont souvent prescrits." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure la dengue sévère, l'hémorragie et le choc." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le paludisme peut entraîner des anémies, des troubles neurologiques et la mort." } }, { "@type": "Question", "name": "Quelles complications de la leptospirose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires." } }, { "@type": "Question", "name": "Quelles complications du virus Zika ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le virus Zika peut causer des malformations congénitales et des troubles neurologiques." } }, { "@type": "Question", "name": "Quelles complications des infections parasitaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les infections parasitaires peuvent entraîner des malnutritions et des troubles digestifs." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour la dengue ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales, avoir des moustiques et des antécédents d'infection." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques, ne pas utiliser de moustiquaires et voyager sans prévention." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la leptospirose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Travail en milieu rural, contact avec des eaux contaminées et absence de vaccination." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le virus Zika ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones à forte densité de moustiques et absence de protection lors de rapports." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections parasitaires ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Conditions d'hygiène précaires, voyage dans des zones endémiques et consommation d'eau contaminée." } } ] } ] }

Sources (10000 au total)

Management Options for Linear Scleroderma ("En Coup de Sabre").

En coup de sabre (ECDS) is a form of linear-scleroderma, primarily affecting the face. Despite effectiveness of pharmacological interventions in the management of lesions, sequelae of cutaneous deform... Review the existing surgical tools for the correction of "en coup de sabre" ECDS lesions and facial deformities.... The authors conducted a literature search for reports on surgical interventions for ECDS deformations, in the electronic databases of PubMed, Scopus, and Cochrane Library Databases.... Twenty-six publications reporting 39 patients were found in the literature. The average age of patients was 25 ± 4.7 years. Thirty-one of the patients were females. Six methods were found in the liter... Different surgical and minimally invasive options exist in the armamentarium of clinicians correcting ECDS deformities. Tailoring the method of correction to patient's needs and expectation is crucial...

Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.

To describe systemic sclerosis (SSc) heart involvement in the ICU.... We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021.... 9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocar... We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be rever...

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.

Recent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that 'metabolic reprogramming' involving the g... Dermal fibroblasts were isolated from five SSc patients and five healthy donors. Cells were cultured in medium with/without TGF-β1 and with/without ALK5, pan-PIM or ATM kinase inhibitors. Extracellula... Enhanced mitochondrial respiration coupled to ATP production was observed in SSc fibroblasts at the expense of spare respiratory capacity. Although no difference was found in glycolysis when comparing... Our data provide evidence for a novel mechanism(s) by which SSc fibroblasts exhibit altered metabolic programs and highlight changes in respiration and dysregulated mitochondrial morphology and functi...

Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.

Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular co... SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-ma... We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptio... We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures....

Association of Race and Risk of Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-B... Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SR... Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, B... Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association....

[Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients].

Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of... Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019). All of them undergo CPET, in addition to the annual systematic screening. Sens... Fifty-two CPET were performed, of which 16 suggested PAH. Resting RHC confirmed PAH in 5 patients and exercise RHC in 7 (diagnostic sensitivity of CPET together with rest and exercise catheterization ... CPET and exercise RHC could detect PAH earlier than established screening in patients with scleroderma disease, allowing early diagnosis....

Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?

Sicca complaints are a frequent reason for rheumatologic consultation. Testing for specific antibodies against Ro/SSA and La/SSB antigens and minor salivary gland (MSG) biopsy are among the main tools... Demographic, clinico-pathological, and laboratory data were recorded in 216 consecutive patients with sicca complaints. All study participants were tested for SSc-specific autoantibodies (against CENP... SSc-specific autoantibodies were detected in 41.7% (90/216) patients evaluated (19% at strong, 22.7% at medium titers) without significant differences between anti-Ro/SSA positive and negative groups.... SSc-specific autoantibodies are frequently detected among patients presenting with sicca complaints and at strong but not medium titers are independently associated with MSG biopsy positivity. Taken t...

Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications.

To evaluate the levels of periostin in patients with systemic sclerosis (SSc) and their association with features of systemic sclerosis.... The levels of periostin were assessed in the serum of 106 SSc patients and 22 healthy controls and by immunofluorescence staining in cardiac tissue from 4 SSc patients and 4 controls. Serum periostin ... Periostin levels were higher in patients with SSc compared to controls and directly correlated to modified Rodnan skin score and echocardiography parameters of left ventricular measurements. Immunoflu... Periostin is elevated in SSc cardiac tissue in vivo and circulating levels of periostin are increased in SSc, correlating with the extent of disease duration, degree of skin fibrosis, and left ventric...